Rosen Firm Reminds Investors of Deadline for PepGen Stock Class Action Suit

Summary

Rosen Law Firm reminds investors who purchased PepGen Inc. (NASDAQ: PEPG) securities between March 7, 2024, and March 3, 2025, of the August 8, 2025, lead plaintiff deadline for a class-action lawsuit. The lawsuit alleges false statements about the efficacy and safety of PepGen’s product PGN-EDO51, causing investor losses when the truth emerged.prnewswire

Impact Analysis

First-Order Effects: The lawsuit could directly affect PepGen’s financial health through potential settlements or legal expenses. It may also harm the company’s reputation, deterring future investments and impacting stock prices negatively.prnewswire+ 2 Second-Order Effects: This legal issue might affect peer companies in the biotech sector, particularly those with similar product portfolios or legal exposures, leading to increased investor scrutiny.prnewswire+ 2 Investment Opportunities: There may be opportunities for short-selling PepGen’s stock or exploring options strategies to hedge against the potential downside risk. Investors should monitor the legal proceedings closely to assess long-term impacts on PepGen’s business viability.GlobeNewswire